BlackRock Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-38,229
| Closed | -$215K | – | 4254 |
|
|
2016
Q1 | $215K | Buy |
38,229
+997
| +3% | +$5.61K | ﹤0.01% | 3130 |
|
|
2015
Q4 | $640K | Buy |
37,232
+67
| +0.2% | +$1.15K | ﹤0.01% | 2883 |
|
|
2015
Q3 | $784K | Buy |
37,165
+296
| +0.8% | +$6.24K | ﹤0.01% | 2777 |
|
|
2015
Q2 | $1.83M | Buy |
36,869
+1,108
| +3% | +$54.8K | ﹤0.01% | 2317 |
|
|
2015
Q1 | $2.8M | Buy |
35,761
+385
| +1% | +$30.1K | ﹤0.01% | 1794 |
|
|
2014
Q4 | $2.14M | Sell |
35,376
-497
| -1% | -$30.1K | ﹤0.01% | 1980 |
|
|
2014
Q3 | $1.53M | Buy |
35,873
+2,289
| +7% | +$97.5K | ﹤0.01% | 2197 |
|
|
2014
Q2 | $2.08M | Buy |
33,584
+2,863
| +9% | +$177K | ﹤0.01% | 2043 |
|
|
2014
Q1 | $2M | Buy |
30,721
+3,035
| +11% | +$197K | ﹤0.01% | 2035 |
|
|
2013
Q4 | $1.56M | Buy |
27,686
+788
| +3% | +$44.4K | ﹤0.01% | 2176 |
|
|
2013
Q3 | $1.65M | Buy |
26,898
+1,903
| +8% | +$117K | ﹤0.01% | 2081 |
|
|
2013
Q2 | $1.46M | Buy |
+24,995
| New | +$1.46M | ﹤0.01% | 2094 |
|